Community Drug Board, Inc.

Community Drug Board, Inc., doing business as CHC Addiction Services, is a tax-exempt nonprofit organization based in Akron, Ohio that delivers integrated addiction treatment, homelessness prevention, and housing support services to federal agencies exclusively as a prime grant recipient and sub-recipient—the organization has never held a federal contract prime or IDV seat. The vendor operates predominately under HUD Continuum of Care Program grants and SAMHSA funding streams, with no federal set-aside certifications.

The organization's customer base is tightly concentrated: the Department of Housing and Urban Development's Assistant Secretary for Community Planning and Development accounts for 60 of 79 total awards in the recent footprint, and SAMHSA accounts for 19 awards across three named program lines (Center for Mental Health Services Projects of Regional and National Significance, State Opioid Response, and related substance abuse block grant streams). This concentration reflects CHC's nonprofit status and grant-focused service model rather than contract diversification. CHC serves as a prime recipient on HUD Continuum of Care Program grants supporting permanent supportive housing and rapid rehousing for homeless individuals and families in Akron, with consecutive annual awards running from at least 2022 through 2026; recent prime awards include a $279,808 Continuum of Care grant (CFDA 14.267) awarded October 1, 2025, and a $400,000 Center for Mental Health Services Projects of Regional and National Significance grant (CFDA 93.532) awarded September 30, 2026, to establish the Summit County Zero Suicide Project, a zero-suicide framework within a federally qualified health center look-alike running through September 29, 2031.

As a sub-recipient, CHC receives federal funding flow-through from the Ohio Department of Mental Health under State Opioid Response (SOR) 3.0 and 4.0 grants, as well as substance abuse prevention and treatment (SAPT) block grants and related opioid-response funding. CHC also functions as a sub-recipient on a Kent State University grant focused on medication-assisted treatment expansion. Recent sub-award activity includes multiple SOR 4.0 and SOR 3.0 passes through Ohio DMH (February 2026, January 2026, December 2025, February 2025, January 2024) and annual SUPTRS (substance use prevention and treatment capacity-building) and SABG (Substance Abuse Block Grant) sub-awards.

Capability delivery centers on inpatient addiction treatment, medication-assisted treatment (methadone and buprenorphine), intensive outpatient treatment, adult and adolescent counseling, gender-specific trauma-informed care, integrated primary healthcare, recovery housing, peer-support services, and coordinated case management and wrap-around services. Grant activity has remained flat to slightly declining year over year (seven awards in 2023 and 2024, six in 2025, three in 2026 to date). Combined dollars obligated across all 79 prime and sub awards total $14.1 million over the available time horizon. Performance occurs in Akron, Ohio, with administrative oversight at the organization's headquarters on East Market Street.